Rubbiano-Parma, Italy | July 12, 2022: – Global contract manufacturer Lincotek has consolidated its market offering with the acquisition of Danco Medical’s facility in Changzhou, Eastern China. The 15,000 sq ft plant, which is ISO 13485 certified, will further enhance the reputation of the Group’s Medical Division for integrated supply chain solutions and services to the global orthopedic devices industry, delivering best-in-class quality, processes and customer service.
This deal is the culmination of a two-part business transaction, which first saw the Italian company acquire Danco Medical’s 35,000 sq ft facility in Warsaw, Indiana, USA earlier this year. The acquisition of the Changzhou plant was the second and final step in the acquisition of Danco Medical.
Danco Medical – leader in Aluminum and Titanium Anodizing – offers complete, end-to-end surface preparation and finishing solutions and a wide range of product identification methods to medical orthopedic device companies. Lincotek Medical, meanwhile, is a leader in offering orthopedic device companies fully integrated supply chain solutions, from device conception and manufacturing through to finishing and polishing, and ultimately packaging. The acquisition creates a perfect match between two growing businesses – expanding the already comprehensive set of capabilities of Lincotek in the medical field and boosting service levels.
Winfried Schaller, the CEO of Lincotek Group, said: “It’s great that we have been able to complete the second part of this important transaction, as Danco is recognised as the leader in metal finishing and complements our existing business perfectly. Danco and Lincotek share the same set of values around service, reliability and customer orientation and, with the acquisition of the Changzhou plant, we are now able to provide even more seamless support to our customers globally.”
“Lincotek is a perfect fit for us,” commented Ross Tiamson, CEO of Danco Medical. “We each have our respective strengths, but together we are an even more formidable force in the market. I am looking forward to working closely with colleagues in Lincotek Medical on this new chapter in our corporate history.”
Lincotek has been advised by Cozen O’Connor for the contractual, legal and labor aspects of the deal, in the person of Partner Christian Moretti and of Associate Beatrice Bottini, in conjunction with Deloitte Legal, in the person of Partner Massimo Zamorani. The Tax & Financial workstream has been handled by Funaro & Co in the persons of Partner Mindy Piatoff Daynes, Principal Matteo Cazzoletti and Director Alexander Contreras.
Danco Medical has been advised by Allen Matkins for the contractual and legal aspects, in the person of Partner Matthew Ertman. The Tax & Financial consultation has been handled by HW LLP in the persons of Partner Louis Hamel and his associate Brian Blackmore.
Lincotek, headquartered in Rubbiano, Parma – Italy, is a global contract manufacturer for services in niche markets including Industrial Gas Turbines, Aviation and Medical Device applications, as well as a leading manufacturer of industrial coating equipment and one of the most respected producers in the Additive Manufacturing field. The Group is family-owned and has more than 1,500 employees, located in 20 production facilities across Europe, North America and Asia.
Medical Headquartered in Warsaw, Indiana, USA, Danco Medical has been meeting the needs of medical device companies for technically superior surface preparation and finishing, providing Titanium and Aluminum Anodizing of machined parts, implants, instruments and devices, as well as electropolishing, passivation and LFCC. Well known for its ability to maintain quality requirements, to meet short deadlines and to retain detailed records, Danco Medical – with around 200 employees – maintains its facilities in Warsaw and Changzhou, China to ISO 13485 certification standards.
For more information, please visit lincotek.com
Media contact: Francesca Pedrotti, firstname.lastname@example.org | +39 345 6203212